HTA insight and reviews to optimise reimbursement strategy
The advent of market access and the sharp focus on payers means that an appropriate reimbursement strategy is no longer optional. HTA submissions differ between countries and the evolving requirements add a complexity which can be difficult to navigate.
At Adelphi Values | PROVE we stay up to date with the latest payer opinion, reimbursement guidelines and recent decisions to ensure we help develop a strategy appropriate for your product. We have a dedicated team of experts who help clients navigate the complex and evolving payer, pricing and reimbursement landscape to optimise market access, value strategy and commercialisation, providing critical insights to:
- Identify, evaluate and prioritise product development opportunities
- Drive insightful clinical development and outcomes research activities that resonate with payers
- Define and build credible, differentiated value propositions and communicate compelling payer evidence.
Our HTA insight combined with communication excellence allows us to help you develop high quality submission documents that present the value of your product clearly, concisely, and supported by the most appropriate evidence. With a history of HTA submissions and clear understanding of geographic and stakeholder needs, we can advise you on the development of a robust market access strategy to optimise the commercial potential both before and after negotiation. Our team of technical communication specialists can also help with publication of research findings to support the value story.
Medical devices may be technically advanced, but unless the multi-perspective value is defined and communicated in the right way, getting to market can become a significant challenge. Adelphi Values understands these complexities. Using our technical expertise gained from working in the HTA and payer environments coupled with landscape and comparative analysis experience, we can help you develop a compelling value story to meet payer needs.